三个皮匠报告—— 严选型全行业研究报告分享下载平台，您的专属行业智库！
欢迎来到三个皮匠报告！
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置：
首页
>
行业数据
>
戈利昔替尼与西达本胺临床疗效对比
戈利昔替尼与西达本胺临床疗效对比
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式：PNG
图片大小：173KB
图片尺寸：1107*707
同报告图片
/
4
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
fCDkuq7ngrkxIHwg5Lqu54K5MiB8IOS6rueCuTMgfAp8LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18Cnwg6Z225ZCR5YyF5ousRUdGUiBFeG9uMjBpbnPnqoHlj5jlnKjlhoXnmoTlpJrnp41FR0ZS56qB5Y+Y5Lqa5Z6LIHwg5L+d55WZ5a+5RUdGUuaVj+aEn+eqgeWPmOWPilQ3OTBN56qB5Y+Y55qE5oqX6IK/55ik5rS75oCnIHwg5pS55ZaE6I2v5Luj5Yqo5Yqb5a2m77yM5Lq65L2T5Y2K6KGw5pyf6ZW/6L6+57qmNTDlsI/ml7bvvIzmr4/ml6XkuIDmrKHlj6PmnI3lrp7njrDmjIHnu63nqLPlrprmipHliLYgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76ISJ6YCa77yM5Zu95YWD6K+B5Yi456CU56m25omA
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
所属报告：
迪哲医药-公司深度报告：小分子创新能力突出商业化前景良好-250617（24页）.pdf
打包全文图表
相关数据
图表50艾玛昔替尼II/III期AS临床数据（应答率）
fCDmjIfmoIcgICAgICAgfCDlr7nnhafnu4TlupTnrZTnjocoJSkgfCDor5Xpqoznu4TlupTnrZTnjocoJSkgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18CnwgQVNBUzIwICAgICB8IDI5LjAgICAgICAgICAgICAgfCA0OC43ICAgICAgICAgICAgIHwKfCBBU0FTNDAgICAgIHwgMTguMyAgICAgICAgICAgICB8IDMyLjEgICAgICAgICAgICAgfAp8IEFTQVM1LzYgICAgfCAxNS42ICAgICAgICAgICAgIHwgNDIuOCAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJpaLkxpIGV0IGFsLiBBIG11bHRpY2VudGVyLCByYW5kb21pemVkLCBkb3VibGUgLSBibGluZCw=
收藏
行业数据
2025-09-28
原图定位
查看详情
图表51艾玛昔替尼II/III期AS数据（较基线变化）
fCDmjIfmoIcgICAgICAgICAgfCBQbGFjZWJvIHwgU0hSMDMwMiA0IG1nIHwKfC0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18CnwgQkFTREFJICAgICAgICB8IC0xLjQzICAgfCAtMi4yMSAgICAgICAgfAp8IEJBU0ZJICAgICAgICAgfCAtMC43OSAgIHwgLTEuMzMgICAgICAgIHwKfCBCQVNNSSAobGluZWFyKXwgLTAuMjkgICB8IC0wLjQwICAgICAgICB8CnwgQVNRb0wgICAgICAgICB8IC0yLjE4ICAgfCAtMy4xMyAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaWi5MaSBldCBhbC4gQSBtdWx0aWNlbnRlciwgcmFuZG9taXplZCwgZG91YmxlLWJsaW5kLA==
收藏
行业数据
2025-09-28
原图定位
查看详情
图34、罗昔替尼各适症国内与美国发进
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
收藏
行业数据
2025-08-19
原图定位
查看详情
吉卡昔替尼乳膏临床试验情况（截至2025.05.29）
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
收藏
行业数据
2025-08-01
原图定位
查看详情
戈利昔替尼与西达本胺的PFS曲线对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与西达本胺不同亚型PTCL的ORR
fCDliIbnsbsgfCDmiIjliKnmmJTmm7/lsLwgWzFdIHwg6KW/6L6+5pys6IO6IFsyXSB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCDooYDnrqHlhY3nlqvmr43nu4bog55U57uG6IOe5reL5be055ikIChBSVRMKSB8IDU2JSB8IDUwJSB8Cnwg6Z2e54m55oyH5Z6L5aSW5ZGoVOe7huiDnua3i+W3tOeYpCAoUFRDTC1OT1MpIHwgNDYlIHwgMjIlIHwKfCDoh6rnhLbmnYDkvKQvVOe7huiDnua3i+W3tOeYpCAoTksvVENMKSB8IDY3JSB8IDE5JSB8Cnwg5YW25LuW5Lqa5Z6LIHwgNDQlIHwgMTElIHw=
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与已获批竞品疗效对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与其它JAK抑制剂的选择性比较
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与西达本胺停药率对比
5qC55o2u5oKo5o+Q5L6b55qE5L+h5oGv77yM5Lul5LiL5piv6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOiNr+eJqSAgICAgICB8IOWBnOiNr+eOhyAgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tfAp8IOaIiOWIqeaYlOabv+WwvCB8IDcuMyUgICB8Cnwg6KW/6L6+5pys6IO6ICAgfCAxNi45JSAgfAoK6LWE5paZ5p2l5rqQ77ya5Zu95a625Yy755aX5L+d6Zqc5bGA77yM6byO5YW06K+B5Yi456CU56m25omA
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与其它JAK抑制剂的PK比较
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与已获批竞品安全性对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼临床开发历程
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
收藏
产业概述
2025-02-06
原图定位
查看详情
POETYKPSO-LTE：2年期氘可来昔替尼用药安全性结果
5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u77yM55Sf5oiQ55qE6KGo5qC85aaC5LiL77yaCgp8IOmhueebriAgICAgICAgIHwg5q+U5L6LICglKSB8CnwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tfAp8IFNBRSAgICAgICAgICB8IDkuNSAgICAgIHwKfCDlr7zoh7TlgZzoja8gQUUgIHwgNC41ICAgICAgfAp8IOatu+S6oSAgICAgICAgIHwgMC41ICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaQnIgSiBEZXJtYXRvbC4gMjAyNDsxOTAoNSk6NjY4LTY3Oe+8jOWNjuazsOeglOeptg==
收藏
行业数据
2024-12-30
原图定位
查看详情
II期临床：氘可来昔替尼vs安慰剂16周ACR-20缓解率
fCDoja/nianlj4rliYLph48gfCBBQ1ItMjDnvJPop6PnjocgKCUpIHwKfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwKfCDmsKLlj6/mnaXmmJTmm7/lsLw2bWcgcWQgKE49NzApIHwgNTAgfAp8IOawouWPr+adpeaYlOabv+WwvDEybWcgcWQgKE49NjcpIHwgNjAgfAp8IOWuieaFsOWJgiAoTj02NikgfCAzMCB8CgrotYTmlpnmnaXmupDvvJpBbm4gUmhldW0gRGlzLiAyMDIyOzgxKDYpOjgxNS04MjLvvIzljY7ms7DnoJTnqbY=
收藏
行业数据
2024-12-30
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模（百万美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
根据国家医保局材料，戈利昔替尼对比西达本胺的临床数据显示，在患者入组基线更差的情况下，戈利昔替尼仍展示出更深缓解、更长生存；且戈利昔替尼对于 PTCL-NOS 等大多数尚无有效治疗手段的亚型疗效优异，填补 PTCL 多个亚型的治疗空白。
行业数据
原图定位
当前图表所属：
迪哲医药-公司深度报告：小分子创新能力突出商业化前景良好-250617（24页）.pdf
公司高管履历
舒沃替尼分子式及结构设计亮点
中国EGFRex20insNSCLC新发患者数量
全球EGFRex20insNSCLC新发患者数量
下载图片或Excel，需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利，扫码领取！
关注公众号『三个皮匠报告』，免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码？
验证即登录，未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》
研搜
0731-84720580
商务合作：really158d
下载Excel
下载图片
原图定位
打包全文图表
收藏
2025-09-28
原图定位
微信扫码登录
手机快捷登录
账号登录
